Evidence map›Paper›PMID 36526599›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Blood Milieu in Acute Myocardial Infarction Reprograms Human Macrophages for Trauma Repair.

Margaux A C Fontaine, Han Jin, Mick Gagliardi, Mat Rousch, Erwin Wijnands, Monika Stoll, Xiaofei Li, Leon Schurgers, Chris Reutelingsperger, Casper Schalkwijk and 13 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Blood Milieu in Acute Myocardial Infarction Reprograms Human Macrophages for Trauma Repair.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 3 countries.

Margaux A C FontaineCardiovascular Research Institute Maastricht University Medical Center (CARIM), Maastricht University, Maastricht, The Netherlands.
Han JinCardiovascular Research Institute Maastricht University Medical Center (CARIM), Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-0955-6289
Mick GagliardiCardiovascular Research Institute Maastricht University Medical Center (CARIM), Maastricht University, Maastricht, The Netherlands.
Mat RouschCardiovascular Research Institute Maastricht University Medical Center (CARIM), Maastricht University, Maastricht, The Netherlands.
Erwin WijnandsCardiovascular Research Institute Maastricht University Medical Center (CARIM), Maastricht University, Maastricht, The Netherlands.
Monika StollCardiovascular Research Institute Maastricht University Medical Center (CARIM), Maastricht University, Maastricht, The Netherlands.
Xiaofei LiDepartment of Pathology, Maastricht University, Maastricht, The Netherlands.
Leon SchurgersCardiovascular Research Institute Maastricht University Medical Center (CARIM), Maastricht University, Maastricht, The Netherlands.
Chris ReutelingspergerCardiovascular Research Institute Maastricht University Medical Center (CARIM), Maastricht University, Maastricht, The Netherlands.
Casper SchalkwijkCardiovascular Research Institute Maastricht University Medical Center (CARIM), Maastricht University, Maastricht, The Netherlands.
Nynke M S van den AkkerCardiovascular Research Institute Maastricht University Medical Center (CARIM), Maastricht University, Maastricht, The Netherlands.
Daniel G M MolinCardiovascular Research Institute Maastricht University Medical Center (CARIM), Maastricht University, Maastricht, The Netherlands.
Lars GullestadDepartment of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Jan EritslandDepartment of Cardiology, Oslo University Hospital Ullevål, University of Oslo, Oslo, Norway.
Pavel HoffmanDepartment of Cardiology, Oslo University Hospital Ullevål, University of Oslo, Oslo, Norway.
Mona SkjellandResearch Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway.
Geir Ø AndersenDepartment of Cardiology, Oslo University Hospital Ullevål, University of Oslo, Oslo, Norway.
Pål AukrustResearch Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway.
Joël KarelDepartment of Data Science and Knowledge Engineering (DKE), Maastricht University, Maastricht, the Netherlands.
Evgueni SmirnovDepartment of Data Science and Knowledge Engineering (DKE), Maastricht University, Maastricht, the Netherlands.
Bente HalvorsenResearch Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway.
Lieve TemmermanCardiovascular Research Institute Maastricht University Medical Center (CARIM), Maastricht University, Maastricht, The Netherlands.ORCID 0000-0003-1102-0640
Erik A L BiessenCardiovascular Research Institute Maastricht University Medical Center (CARIM), Maastricht University, Maastricht, The Netherlands.
Maastricht University Medical Centre · NLOslo University Hospital · NOMaastricht University · NLUniversity of Münster · DE

Funding

China Scholarship Council 201609120004Dutch Heart FoundationInterreg Va program EMR: Healthy Ageing Interreg Va program EMR: INFLOWInterreg VlaN: Trans-Tech Diagnostics Netherlands Heart Foundation: Queen of HeartsNetherlands Heart Foundation CVD 2017T100Netherlands Organization for Scientific Research 40-42600-98-13007Netherlands Organization for Scientific Research 40-45700-98-2010Stichting voor de Technische Wetenschappen 13568
6 · The paper itself

Abstract

Acute myocardial infarction (AMI) is accompanied by a systemic trauma response that impacts the whole body, including blood. This study addresses whether macrophages, key players in trauma repair, sense and respond to these changes. For this, healthy human monocyte-derived macrophages are exposed to 20% human AMI (n = 50) or control (n = 20) serum and analyzed by transcriptional and multiparameter functional screening followed by network-guided data interpretation and drug repurposing. Results are validated in an independent cohort at functional level (n = 47 AMI, n = 25 control) and in a public dataset. AMI serum exposure results in an overt AMI signature, enriched in debris cleaning, mitosis, and immune pathways. Moreover, gene networks associated with AMI and with poor clinical prognosis in AMI are identified. Network-guided drug screening on the latter unveils prostaglandin E2 (PGE2) signaling as target for clinical intervention in detrimental macrophage imprinting during AMI trauma healing. The results demonstrate pronounced context-induced macrophage reprogramming by the AMI systemic environment, to a degree decisive for patient prognosis. This offers new opportunities for targeted intervention and optimized cardiovascular disease risk management.

Indexed as

MacrophagesMyocardial InfarctionGene Regulatory NetworksHumansPrognosisacute myocardial infarctionheart failureinflammationmacrophage reprogrammingplasticityrepair

Identifiers

PMID36526599
PMCPMC9929255
OpenAlexW4311682400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.